While CBD has been one of the stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer.
There is every sign of big continued interest in medical and recreational marijuana. And while such products should not be confused with CBD, we can expect some of that interest to rub off on the CBD market.
Meanwhile, there is likely to be increased scientific interest in trying to establish how efficacious CBD really is for health, pain-relief and general wellbeing.
Globally 2019 will continue to be a mixed bag for CBD, with growth expected to continue at a rapid pace in established markets while barriers remain in smaller or non-existent ones.